Growth inhibition of unresectable tumors induced by hepatic cryoablation: Report of two cases

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 231-234

  Osada, Shinji ^a   Imai, Hisashi ^a   Yawata, Kazunori ^a   Tanahashi, Toshiyuki ^a   Sakashita, Fumio ^a   Tanaka, Chihiro ^a   Sugiyama, Yasuyuki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ablation therapy; Hepatic metastasis; Percutaneous cryosurgery; Polysaccharide K; Unresectable liver tumor

Indexed keywords

KRESTIN;

ADULT; ARTICLE; CANCER INHIBITION; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CRYOSURGERY; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL STROMAL TUMOR; HOSPITALIZATION; HUMAN; LIVER METASTASIS; LIVER SURGERY; LOCAL ANESTHESIA; MALE; MULTIPLE CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME; TUMOR VOLUME;

CRYOSURGERY; CYTOKINES; FATAL OUTCOME; GASTROINTESTINAL STROMAL TUMORS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETREATMENT; STOMACH NEOPLASMS; T-LYMPHOCYTES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41549133507     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Erce C, Parks RW: Interstitial ablative techniques for hepatic tumours. Br J Surg 2003, 90:272-289.
2. Garcea G, Polemonivi N, O'Leary E, Lloyd TD, Dennison AR, Berry DP: Two-stage liver resection and chemotherapy for bilobar colorectal liver metastases. Eur J Surg Oncol 2004; 30:759-764.
3. Decadt B, Siriwardena AK: Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 2004; 5:550-560.
4. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA: Recurrence and out comes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004; 239:818-825.
5. Johnson LB, Krebs TL, Van Echo D, Plotkin JS, Njoku M, Wong JJ, Daly BD, Kuo PC: Cytoablative therapy with combined resection and cryosurgery for limited bilobar hepatic colorectal metastases. Am J Surg 1997; 174:610-613.
6. Weaver ML, Ashton JG, Zemel R: Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998; 14:163-170.
7. Adam R, Hagopian EJ, Linhares M, Krissat J, Savier E, Azoulay D, Kunstlinger F, Castaing D, Bismuth H: A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002; 137:1332-1339.
8. Poston G: Cryosurgery for colorectal liver metastases. Hepatogastroenterology 2001; 48:323-324.
9. Hamad GG, Neifeld JP: Biochemical, hematologic, and immunologic alterations following hepatic cryotherapy. Semin Surg Oncol 1998, 14:122-128.
10. Lin DY, Lin SM, Liaw YF: Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12:319-328.
11. Hamazoe R, Hirooka Y, Ohtani S, Katoh T, Kaibara N: Intraoperative microwave tissue coagulation as treatment for patients with nonresectable hepatocellular carcinoma. Cancer 1995; 75:794-800.
12. Hanna NN: Radiofrequency ablation of primary and metastatic hepatic malignancies. Clin Colorectal Cancer 2004, 4:92-100.
13. Ohno T, Kawano K, Yokoyama H, Tahara K, Sasaki A, Aramaki M, Kitano S: Microwave coagulation therapy accelerates growth of cancer in rat liver. J Hepatol 2002; 36:774-779.
14. Shibata T, Niinobu T, Ogata N, Takami M: Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000; 89:276-284.
15. Schell SR, Wessels FJ, Abouhamze A, Moldawer LL, Copeland EM: Pro- and anti-inflammatory cytokine production after radiofrequency ablation of unresectacle hepatic tumors. J Am Coll Surg 2002; 195:774-781.
16. Han B, Iftekhar A, Bischof JC: Improved cryosurgery by use of thermophysical and inflammatory adjuvants. Technol Cancer Res Treat 2004; 3:103-111.
17. Urano M, Tanaka C, Sugiyama Y, Miya K, Saji S: Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology 2003; 46:238-245.
18. Joosten JJ, vanMuijen GN, Wobbes T, Ruers TJ: Cryosurgery of tumor tissue causes endoxin tolerance through an inflammatory response. Anticancer Res 2003; 23:427-432.
19. Seifert JK, France MP, Zhao J, Bolton EJ, Finlay I, Junginger T, Morris DL: Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg 2002; 26:1333-1341.
20. Teague BD, Court FG, Morrison CP, Kho M, Wemyss-Holden SA, Maddern GJ: Electrolytic liver ablation is not associated with evidence of a systemic inflammatory response syndrome. Br J Surg 2004; 91:178-183.
21. Seifert JK, Morris DL: World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23:109-113.
22. Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, Granchi J, Curley SA: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178:592-599.
23. Haddad FF, Chapman WC, Wright JK, Blair TK, Pinson CW: Clinical experience with cryosurgery for advanced hepatobiliary tumors. J Surg Res 1998; 75:103.
24. Blackwell TS, Debelak JP, Venkatakrishnan A, Schot DJ, Harley DH, Pinson CW, Williams P, Washington K, Christman JW, Chapman WC: Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production. Surgery 1999; 126:518-526.
25. Mala T, Edwin B, Mathisen O, Tillung T, Fosse E, Bergan A, SOreide O, Gladhaug I: Cryoablation of colorectal liver metastases: minimally invasive tumour control. Scand J Gastroenterol 2004; 39:571-578.
26. Seifert JK, Junginger T: Prognostic factors for cryotherapy of colorectal liver metastases. Eur J Surg Oncol 2004; 30:34-40.
27. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793.
28. Nishimura T, Nakui M, Sato M, Iwakabe K, Kitamura H, Sekimoto M, Ohta A, Koda T, Nishimura S: The critical role of Th-1 dominant immunity in tumor immunology. Cancer Chemother Pharmacol 2000; 46:52-61.
29. Fisher M, Yang LX: Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res 2002; 22:1737-1754.
30. Garcia-Lora A, Martinez M, Pedrinaci S, Garrido F: Different regulation of PKC isoenzymes and MAPK by PSK and IL-2 in the proliferative and cytotoxic activities of the NKL human natural killer cell line. Cancer Immunol Immunother 2003; 52:59-64.
31. Ishihara Y, Iijima H, Matsunaga K: Contribution of cytokines on the suppression of lung metastasis. Biotherapy 1998; 11:267-275.